Screening for Cervical Cancer. Female members with a cervix shall receive Papanicolaou (Pap) testing starting at the onset of sexual activity, but at least by 18 years of age, and every three years thereafter until reaching 65 years of age if prior testing has been consistently normal and the member has been confirmed to be not at high risk. If the member is at high risk, the frequency shall be at least annual.
Appears in 3 contracts
Samples: Medicaid Managed Care Services Agreement (Molina Healthcare Inc), Benefit Package Agreement, Medicaid Managed Care Services Agreement (BHC Physician Services of Kentucky LLC)
Screening for Cervical Cancer. Female members Members with a cervix shall receive Papanicolaou (Pap) cytopathology testing starting at the onset of sexual activity, but at least by 18 twenty-one (21) years of age, and every three (3) years thereafter until reaching 65 sixty-five (65) years of age age, if prior testing has been consistently normal and the member Member has been confirmed to be not at high risk. If the member Member is at high risk, the testing frequency shall be at least annual.
Appears in 1 contract
Samples: Medicaid Long Term Services Agreement (Amerigroup Corp)
Screening for Cervical Cancer. Female members with a cervix shall receive Papanicolaou (Pap) testing starting at the onset of sexual activity, but at least by 18 eighteen (18) years of age, and every three years thereafter until reaching 65 sixty-five (65) years of age if prior testing has been consistently normal and the member has been confirmed to be not at high risk. If the member is at high risk, the testing frequency shall be at least annual.
Appears in 1 contract
Samples: Medicaid Managed Care Services Agreement (Molina Healthcare Inc)
